Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 495 of 6351
-
New weekly shot could help diabetics shed pounds
Disease control OngoingThe purpose of this clinical study is to learn about the safety and effects of the study medicine to help adults with obesity or overweight and type 2 diabetes lose weight. Being overweight or obese means carrying too much body weight. Type 2 diabetes is a condition where there i…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New weekly injection could help fight obesity
Disease control Recruiting nowThe purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111 (the treat…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New DNA test could spot uterine cancer from a urine sample
Diagnosis Recruiting nowThe goal of this observational study is to investigate the clinical utility of DNA-methylation testing in urine and vaginal samples collected by patients and cervical samples collected by clinicians, to determine the risk of endometrial cancer in symptomatic women with postmenopa…
Sponsor: University of Aarhus • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
Radioactive antibody targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowA Phase 1/2a Dose Escalation and Expansion Study of the Safety, Tolerability, and Preliminary Clinical Activity of 177LuBetaBart, a 177Lu-Labeled Anti-B7-H3 Monoclonal Antibody, in Patients with Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Phase 1/2 • Sponsor: Radiopharm Theranostics, Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Gene therapy trial aims to tame deadly heart rhythms
Disease control Recruiting nowThis is a Phase 1b, Multicenter, Open-Label, Dose Finding Study to Investigate the Safety and Tolerability of a Single Intravenous Dose of SGT-501 in participants with catecholaminergic polymorphic ventricular tachycardia (CPVT). The first-in-human (FIH) safety study will focus o…
Phase 1 • Sponsor: Solid Biosciences Inc. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Could a dissolving film under the tongue stop PTSD after a crash?
Disease control Recruiting nowThis study will examine the safety and efficacy of BXCL501 to reduce ASR symptoms and behavioral changes among patients presenting to the Emergency Department (ED) after Motor Vehicle Collision (MVC). Specifically, the investigators will perform the BXCL501 (BASIS) Trial, a doubl…
Phase 2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Your Phone's microphone could soon screen for lung disease
Diagnosis OngoingChronic Obstructive Pulmonary Disease (COPD) is a leading cause of morbidity and mortality worldwide, yet early detection remains challenging-especially in primary care settings where spirometry, the diagnostic gold standard, is often unavailable. This study aims to develop and v…
Sponsor: Sir Run Run Shaw Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
New hope for depression-related daytime sleepiness? phase 3 trial underway
Symptom relief Recruiting nowCLARITY (Clinical Assessment of Response in the Treatment of Depression with Daytime Sleepiness Using Solriamfetol) is a Phase 3, double-blind, placebo-controlled, multicenter randomized withdrawal trial in patients with major depressive disorder (MDD) with excessive daytime slee…
Phase 3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
New combo therapy aims to shrink tough rectal cancers before surgery
Disease control Recruiting nowWhy is this study conducted? The purpose of this study is to improve the treatment efficacy, particularly the pathological complete response rate, in patients with high-risk/extremely high-risk locally advanced rectal cancer (LARC). In recent years, with the combination of neoadj…
Phase 2/3 • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Can a three-drug cocktail shrink advanced bile-duct tumors?
Disease control CompletedThis prospective, single-center, single-arm phase II clinical trial was designed to evaluate the efficacy and safety of bevacizumab plus nab-paclitaxel and S-1 as second-line treatment for patients with advanced biliary tract adenocarcinoma who experienced disease progression or …
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could a scent and a touch soothe Post-Surgery pain?
Symptom relief CompletedCesarean delivery is a common surgical procedure associated with postoperative pain, anxiety, and reduced maternal comfort during the early postpartum period. Non-pharmacological interventions such as aromatherapy and massage have been suggested as supportive approaches for impro…
Sponsor: Uşak University • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
New drug targets Hard-to-Treat prostate cancer
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, efficacy, tolerability, and pharmacokinetics (PK) of FG-3246, a cluster of differentiation 46 (CD46) targeting antibody-drug conjugate (ADC), in the treatment of participants with mCRPC who have progressed following treatment w…
Phase 2 • Sponsor: Kyntra Bio • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New combo therapy offers hope for hard-to-treat breast cancer
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the efficacy and safety of toripalimab combined with radiochemotherapy as perioperative therapy in HER2-negative breast cancer patients insensitive to neoadjuvant chemotherapy. This was a multicohort, single-center exploratory clini…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New hope against Drug-Resistant TB: phase II trial launches
Disease control Not yet recruitingThis study is a multicenter, randomized, double-blind, placebo-controlled phase II clinical trial to evaluate the safety, tolerability, and preliminary efficacy of acetohydroxamic acid (AHA) capsules combined with short-course regimens (BDLLfxC or BDCZ) in patients with multidrug…
Phase 2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Could surgery after chemo double survival for advanced stomach cancer?
Disease control OngoingThe goal of this clinical trial is to evaluate the impact of conversion surgery on overall survival (OS) in patients with gastric cancer peritoneal metastases (GCPM) who show a good response to preoperative systemic therapy (including first-line chemotherapy with or without targe…
Phase 2/3 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Mini-Tumors in a dish may guide pancreatic cancer treatment
Knowledge-focused Recruiting now1. Background Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies worldwide, with a 5-year survival rate below 10%. Systemic chemotherapy is the mainstay of treatment for the majority of patients who present with unresectable disease. However, the …
Sponsor: Beijing Daxiang Biotech Co., Ltd • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Can a Head-Down tilt or ancient herbs save lives in severe pneumonia?
Disease control Not yet recruiting1. Background Severe pneumonia with respiratory failure carries a high mortality rate. Preliminary evidence suggests potential benefits for interventions such as Trendelenburg Position and certain herbal formulations used within an integrative treatment framework. However, robust…
Phase 4 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
AI-Powered exercise bike aims to personalize senior fitness
Prevention Recruiting nowThis clinical trial aims to evaluate the effectiveness of an artificial intelligence of things (AIoT)-based exercise system for seniors. Participants will undergo a 12-week AIoT-based cycle ergometer training program. Physical fitness and functional performance will be assessed a…
Sponsor: I-Shou University • Aim: Prevention
Last updated Aug 28, 2026 00:00 UTC
-
Could a simple exercise class help us age better?
Prevention By invitation onlyIntroduction: Extension projects focused on physical activity can offer health practices and promote quality of life for participants of different ages. Investing in extension projects with a research interface can contribute to relevant insights for teaching knowledge. Furthermo…
Phase 1 • Sponsor: Federal University of the Valleys of Jequitinhonha and Mucuri • Aim: Prevention
Last updated Aug 19, 2026 00:00 UTC
-
Universal CAR-T cells take on lupus and more in early trial
Disease control Recruiting nowA single arm, open-label pilot study is designed to determine the safety and effectiveness of anti-CD19/BCMA U CAR T cells in patients with autoimmune diseases. 60 patients are planned to be enrolled in the dose-escalation trial.
Early phase 1 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC